DrugsControl Media Services
DrugsControl.org

News Detail

China Cracks Down on Illegal Copies of Novo’s Obesity Drug (20-09-2024)

Beijing, 20 Sept 2024: China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster diabetes and obesity treatment, in a bid to curb a gray market that caters to growing demand for such therapies amid a global supp......
View Details

Source : Bloomberg
Asia Pacific Rim Business China Consumer Goods Retail Consumer Discretionary Company News Biotech & Pharma Europe General Health Care Industry Internet Legal North America Technology Unites States World

Related News